Merck

Janux pairs up with Merck for $1B-plus T-cell engager deal
Fierce Biotech
Fri, 12/18/20 - 11:04 am
Merck
Janux Therapeutics
R&D
T-cell engager
cancer
FDA grants priority review to KEYTRUDA for treatment of esophageal and gastroesophageal junction cancer
Pharmaceutical Business Review
Fri, 12/18/20 - 10:50 am
Merck
Keytruda
FDA
esophageal cancer
gastroesophageal cancer
Merck gets positive CHMP opinion for Keytruda as first-line treatment for dMMR colorectal cancer
Pharmaceutical Business Review
Mon, 12/14/20 - 11:03 am
Merck
CHMP
Keytruda
colorectal cancer
[video+transcript]Here's Why Merck Made a Mistake by Selling Its Moderna Stake
Motley Fool
Mon, 12/14/20 - 10:36 am
Merck
Moderna Therapeutics
vaccinces
COVID-19
Boehringer inks $1.5B NBE buyout, joining Merck in new cancer race
Fierce Biotech
Thu, 12/10/20 - 11:27 am
Boehringer Ingelheim
NBE Therapeutics
M&A
Merck
antibody-drug conjugate
ROR1
Beating Merck, Pfizer gets priority review as the first Prevnar follow-up heads to the FDA
Endpoints
Wed, 12/9/20 - 10:41 am
Pfizer
20VPnC
Prevnar
pneumococcal disease
Merck
FDA
[video+transcript]Here's Why Biotech Deals Are All the Rage Right Now
Motley Fool
Sat, 12/5/20 - 11:24 pm
biotech
M&A
Biogen
SAGE Therapeutics
Eli Lilly
Precision Biosciences
Merck
OncoImmune
Merck Sells Stake in Moderna as Vaccine Gets FDA Review
Bloomberg
Wed, 12/2/20 - 10:36 am
Merck
Moderna Therapeutics
COVID-19
vaccines
Merck to acquire Oncolmmune, accelerating development of COVID-19 treatment candidate
Biopharma Reporter
Mon, 11/23/20 - 10:43 am
Merck
OncoImmune
M&A
CD24Fc
COVID-19
Eiger nabs the first FDA approval for Progeria, an ultra-rare premature aging disease, with an old Merck drug
Endpoints
Mon, 11/23/20 - 10:11 am
Eiger BioPharmaceuticals
Merck
FDA
progeria
Merck's Keytruda nets another approval, this time in triple negative breast cancer. Can it catch up to Tecentriq?
Endpoints
Mon, 11/16/20 - 10:18 am
Merck
Keytruda
triple negative breast cancer
Could Keytruda/Lenvima Combo Help Treat Advanced Renal Cell Carcinoma?
BioSpace
Tue, 11/10/20 - 11:10 am
Merck
Eisai
Keytruda
Lenvima
clinical trials
advanced renal cell carcinoma
Merck pulls the plug on a study evaluating blockbuster Keytruda with Yervoy for NSCLC
Endpoints
Tue, 11/10/20 - 10:45 am
Merck
Keytruda
Yervoy
clinical trials
non-small cell lung cancer
Merck inks $2.8B VelosBio buyout to snag anti-ROR1 ADC
Fierce Biotech
Thu, 11/5/20 - 11:12 am
Merck
VelosBio
M&A
antibody-drug conjugate
diffuse large B-cell lymphoma
Drugs and vaccines may not swiftly end pandemic, says Merck & Co’s CEO
Pharmaforum
Tue, 11/3/20 - 10:57 am
Merck
Pharma CEOs
Ken Frazier
pandemic
COVID-19
vaccines
Watch out, Merck: FDA grants Regeneron, Sanofi's Libtayo priority review for coveted first-line use in lung cancer
Fierce Pharma
Thu, 10/29/20 - 12:17 pm
Regeneron
Sanofi
Libtayo
FDA
priority review
non-small cell lung cancer
Merck
Keytruda
Sanofi to Evaluate THOR-707 with Merck's Checkpoint Inhibitor Keytruda
BioSpace
Thu, 10/29/20 - 12:14 pm
Sanofi
Merck
THOR-707
Keytruda
solid tumors
Merck raises annual profit outlook as Keytruda drives profit beat
CNBC
Wed, 10/28/20 - 10:39 am
Merck
earnings
Keytruda
Merck looks ahead to a COVID-19 drug and vaccine—and a Gardasil recovery—as pandemic takes a $2.5B toll
Fierce Pharma
Tue, 10/27/20 - 11:17 pm
Merck
earnings
Gardasil
pandemic
COVID-19
These 2 Pharmas Have Made Their Pipelines a Competitive Advantage
Motley Fool
Tue, 10/27/20 - 10:33 am
Merck
Bristol-Myers Squibb
competition

Pages